Home › Ironwood Pharmaceuticals Initiates Phase III Trial Of 72 mcg Linaclotide In Adult Patients With Chronic Idiopathic Constipation
 

Keywords :   


Ironwood Pharmaceuticals Initiates Phase III Trial Of 72 mcg Linaclotide In Adult Patients With Chronic Idiopathic Constipation

2014-11-05 05:57:43| drugdiscoveryonline Home Page

Ironwood Pharmaceuticals, Inc. announced recently the initiation of a Phase III clinical trial in the U.S. evaluating a 72 mcg capsule of linaclotide to be taken once per day for the treatment of adults suffering from chronic idiopathic constipation (CIC)

Tags: iii trial adult phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.11LL
16.11 1.2.3.4.5.6.
16.11KTF 21SVTW
16.11 a
16.11 Lord Finesse From The Crates To The File
16.11AB6IX
16.11TOMIX JR EF63()
16.11
More »